Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icotinib vs Whole Brain Radiotherapy in EGFR-mutant NSCLC with Brain Metastases
NCT01724801Phase 3Completed
- Sponsor
- Guangdong Association of Clinical Trials
- Start
- Oct 2012
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of icotinib in non-small cell lung cancer (NSCLC), sponsored by Guangdong Association of Clinical Trials. Started Oct 2012; status: completed.
02
Drugs
icotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01724801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01724801.